Documenting the achievement of elimination as a public health problem GPELF dossier template

1. Documenting the achievement of elimination as a public health problem GPELF dossier template Preventive Chemotherapy and Transmission Control Unit Department of Control of Neglected Tropical Diseases World Health Organization

2. M&E WG subgroup 2 meeting, Aug 2014 Draft template presented and reviewed - • to serve as a tool for national LF programmes to summarize minimal information needed to document LF elimination • to standardize presentation of information to make review of dossiers easier • Provide complete information required for review process • Reduce clarifications needed by reviewers after submission of dossier

3. Process • Draft narrative section and data tables developed • ‘Pilot testing’ template in Philippines and Bangladesh • Harmonizing with… • WHO TAS eligibility and reporting form • WHO Joint Reporting Form and PC Epidemiological Data Reporting Form • To be auto-generated by the Integrated NTD Database

4. Format • Narrative • Word document • Overall description of the programme • A few key summary data tables • Data Annex • Excel file with 7 summary data tables • Line listing of IU data by topic

5. Structure

6. 1. General description • Overall geographic and economic features of the country • Administrative levels table • Health system • LF programme overview • Role of partners table • Regional context

7. 2. History of LF • Detailed description of pre-programme phase • Data used to classify implementation units as endemic or non-endemic • Map of endemicity

8. 3. Interventions for interruption of transmission • MDA (required) • Implementation • Reported overage summary table • Supplemental interventions • Oncho MDA • STH deworming • Vector control • Test and treat • Environmental or economic improvements

9. 4. Assessment of interventions for interruption of transmission • Sentinel and spot-check sites (required) • Surveys for stopping MDA (required)

10. 5. Surveillance • Cross-sectional surveys, including post-MDA TAS (required) • Ongoing surveillance • Entomological monitoring (if available)

11. 6. Special issues • Special circumstances that have affected implementation or surveillance of the programme, including: • Stability or security • Migration • Mobile populations • Special population groups • Table with summary of investigations or surveillance in special population groups

12. 7. MMDP • Disease burden (required) • Number of lymphoedema and hydrocele cases per IU • Toolkit contains menu of options for assessing disease burden (e.g. population-based surveys, leveraging current GPELF activities (MDA, coverage survey, community-based TAS), house-to-house line listing • Availability of MMDP services (required) • Availability of at least one health facility in the IU known to have cases that provide MMDP services • Questionnaire to district NTD focal points • Quality of MMDP services (required) • Number of facilities providing MMDP services surveyed for quality assessment • Toolkit contains a tool for direct facility inspection (subset of facilities within an IU with known burden)

13. Other sections 8. Bibliography • Key articles and reports to be kept on file in national programme office 9. Abbreviations

14. Next steps • Incorporate comments from meetings (Sept-Oct 2014) • Final draft template circulated to ROs for comments (Oct 2014) • Submit to STAG M&E Working Group (Oct 2014) • Submit to STAG-NTD April 2015 as part of Elimination Process SOP for recommendation • Distribute to WHO RO and CO for distribution to country programs (May 2015)